Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Deciphera ...

The trial is being carried out in 16 nations and regions, including Asia, North America, Europe, and South America.

While fever is typically a sign of infection, a persistent, unexplained fever without any identifiable cause could be an ...

PE Hub has rounded up six deals going back to early January involving companies in the oncology segment, starting with the ...

Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients[1],[2] Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL ...

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in adults with alkaptonuria, Cycle ...

In this interview with TRUST-I and TRUST-II trial investigator, Jorge J. Nieva, MD, USC Keck School of Medicine, he walks through the design of the trials, the results that supported the FDA approval, ...

Combination therapy with savolitinib and osimertinib shows promising results in treating advanced NSCLC with EGFR mutations ...